Vitamin C during pregnancy supports early brain development, OHSU study finds
Findings underscore importance of nutrition for both healthy pregnancy, early childhood development; OHSU expanding prenatal nutrition counseling, access to healthy foods.
Research
More Research Stories
- Latest Stories
OHSU names new director of Oregon National Primate Research Center
March 17, 2023
Skip Bohm, a veterinarian, will lead center beginning in August.
Opioid overdose risk is 10 times greater for those recently released from prison
March 10, 2023
Findings from OHSU, OSU underscore need for expanded, improved programming to protect people re-entering communities.
Study reveals limitations in evaluating gene editing technology in human embryos
March 07, 2023
OHSU-led research identifies new scientific hurdles in using gene repair to prevent inherited disease.
OHSU leading effort to make cancer trials more inclusive
March 02, 2023
Team at Oregon Health & Science University working to bring benefits of clinical trials to people in underserved communities.
Making Hepatitis C care easier when treatment seems impossible
February 23, 2023
Pilot project simplifies testing, treatment for some of Oregon’s most vulnerable patients.
Pill for skin disease also curbs excessive drinking
February 21, 2023
Study from OHSU, research institutions nationwide lands on promising treatment for alcohol use disorder.
OHSU clinical trial tests exercise for multiple sclerosis treatment
February 20, 2023
Research examines whether exercise helps restore myelin in the central nervous system to address MS symptoms.
OHSU study finds significant gaps in menstrual research and clinical care
February 15, 2023
Physician-scientists with OHSU Center for Women’s Health urge prioritization of sustainable, accessible, inclusive menstrual technology.
OHSU confirms first nonhuman primate model of Usher syndrome
February 13, 2023
Researchers now have a model for testing gene therapy as a treatment for leading cause of blindness-deafness.
OHSU researchers identify promising next-generation cancer treatment
February 10, 2023
Chemistry discovery points to next generation inhibitors of PARP-1, a critical target in ovarian, breast and prostate cancers.